Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on SCLN
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Sciclone Pharmaceuticals, Inc. (NQ:SCLN)
Delayed:
4.84
-0.13 (2.62%)
Trade Now!
Previous Close
$4.97
52 Week High
$7.58
Open
$4.93
52 Week Low
$3.68
Day High
$4.93
P/E
30.25
Day Low
$4.78
EPS
$0.16
Volume
86,356
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 16, 2013 05:09 PM
Form 8-K SCICLONE PHARMACEUTICALS For: May 13
May 16, 2013 04:14 PM
SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting
May 16, 2013 04:13 PM
Sciclone (SCLN) Enters Licensing Agreement with Neucardin in East Asia
May 16, 2013 04:00 PM
SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
May 16, 2013 04:00 PM
SciClone Reports Anticipated Financial Results for the First Quarter 2013
May 13, 2013 06:06 AM
Form NT 10-Q SCICLONE PHARMACEUTICALS For: Mar 31
May 10, 2013 01:14 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 01 Filed by: Zhao Hong
Apr 8, 2013 03:04 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Wong Stephanie
Apr 8, 2013 02:57 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Yin Min
Apr 8, 2013 02:49 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Xie Lan
View All Articles
May 16, 2013 04:14 PM
SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting
Apr 1, 2013 04:06 PM
Sciclone Pharmaceuticals, Inc. (SCLN) Misses Q4 EPS by 8c, Guides FY13
Mar 22, 2013 06:21 AM
SciClone (SCLN) Appoints Hong Zhao as CEO
Jan 7, 2013 06:31 AM
Sciclone (SCLN) Issues FY13 Outlook; Revs Lighter than Expectations
Nov 9, 2012 06:53 AM
Sciclone Pharmaceuticals, Inc. (SCLN) Misses Q3 EPS by 1c; Lowers FY12 Outlook
Aug 8, 2012 04:28 PM
Sciclone Pharmaceuticals, Inc. (SCLN) Posts Mixed Q2 Results
May 9, 2012 04:00 PM
Sciclone Pharmaceuticals, Inc. (SCLn) Tops Q1 EPS by 1c
Mar 13, 2012 04:08 PM
Sciclone Pharma (SCLN) Reports Better-Than-Expected Q4 Results; Guides FY12
Nov 8, 2011 08:03 AM
Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q3 EPS by 2c; Authorizes $20M Buyback
Aug 9, 2011 04:09 PM
Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q2 EPS by 3c
View All Major News
May 16, 2013 04:14 PM
SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting
May 16, 2013 04:13 PM
Sciclone (SCLN) Enters Licensing Agreement with Neucardin in East Asia
Apr 8, 2013 06:22 AM
Sciclone (SCLN) Names New Independent Registered Public Accounting Firm
Apr 2, 2013 09:31 AM
StreetInsider.com Pre-Open Movers 4/02: (BGCP) (OMPI) (NUAN) Higher; (AFFY) (NAT) (HPQ) Lower (more...)
Apr 1, 2013 06:11 PM
Streetinsider.com After-Hours Movers 4/01: (BGCP) (NUAN) (HUM) Higher; (NAT) (NDAQ) (SCVL) Lower (more...)
Apr 1, 2013 04:06 PM
Sciclone Pharmaceuticals, Inc. (SCLN) Misses Q4 EPS by 8c, Guides FY13
Mar 22, 2013 06:21 AM
SciClone (SCLN) Appoints Hong Zhao as CEO
Jan 14, 2013 06:31 AM
Sciclone Pharma (SCLN) Appoints Simon Li to Board
Jan 7, 2013 06:31 AM
Sciclone (SCLN) Issues FY13 Outlook; Revs Lighter than Expectations
Nov 9, 2012 01:16 PM
Unusual 11 Mid-Day Movers 11/09: (ZIP) (KYAK) (SCLN) Higher; (GRPN) (DTSI) (RNDY) Lower
View All Reports
May 16, 2013 04:00 PM
SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
May 16, 2013 04:00 PM
SciClone Reports Anticipated Financial Results for the First Quarter 2013
Apr 8, 2013 06:00 AM
SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm
Apr 1, 2013 04:00 PM
SciClone Reports 2012 Financial Results and 2013 Outlook
Apr 1, 2013 07:25 AM
SciClone Pharmaceuticals to Report 2012 Financial Results and 2013 Outlook on April 1st
Mar 28, 2013 08:35 PM
SciClone Pharmaceuticals, Inc. Is Being Investigated on Behalf of Shareholders
View All Press Releases
May 16, 2013 05:09 PM
Form 8-K SCICLONE PHARMACEUTICALS For: May 13
May 13, 2013 06:06 AM
Form NT 10-Q SCICLONE PHARMACEUTICALS For: Mar 31
May 10, 2013 01:14 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 01 Filed by: Zhao Hong
Apr 8, 2013 03:04 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Wong Stephanie
Apr 8, 2013 02:57 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Yin Min
Apr 8, 2013 02:49 PM
Form 4 SCICLONE PHARMACEUTICALS For: Apr 04 Filed by: Xie Lan
Apr 8, 2013 02:37 PM
Form 4 SCICLONE PHARMACEUTICALS For: Aug 31 Filed by: Blobel Friedhelm
Apr 8, 2013 06:17 AM
Form 8-K SCICLONE PHARMACEUTICALS For: Apr 08
Apr 5, 2013 05:14 PM
Form 8-K SCICLONE PHARMACEUTICALS For: Apr 01
Apr 5, 2013 04:19 PM
Form 8-K/A SCICLONE PHARMACEUTICALS For: Feb 18
View All Filings
Entities mentioned with
SCLN
Earnings
|
View Related Stories »
Stock Buyback
|
View Related Stories »
BWS Financial
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Morning Movers
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Morgan Stanley
|
View Related Stories »
Dividend
|
View Related Stories »
Bank of America
|
View Related Stories »
Carl Icahn
|
View Related Stories »
Soleil Securities
|
View Related Stories »
Citi
|
View Related Stories »
Needham & Company
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
Trading Radar
|
View Related Stories »
S3
|
View Related Stories »
Bankruptcy
|
View Related Stories »
13G
|
View Related Stories »
RBC Capital
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Cowen & Co
|
View Related Stories »
Susquehanna International Group of Companies
|
View Related Stories »
SAC Capital
|
View Related Stories »
Raymond James
|
View Related Stories »
Steven A. Cohen
|
View Related Stories »
Show More...
View All Entities